Sumitomo Pharma Co., Ltd. (FRA:DPM)

Market Cap	4.26B +138.2%
Revenue (ttm)	2.46B +21.6%
Net Income	598.04M
EPS	1.51
Shares Out	n/a
PE Ratio	7.13
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	418
Open	10.66
Previous Close	10.60
Day's Range	10.66 - 10.66
52-Week Range	3.96 - 18.80
Beta	n/a
RSI	45.31
Earnings Date	May 13, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has coll...

• Industry: Pharmaceutical Preparations
• Founded: 1897
• Employees: 3,832
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: DPM

Financial Performance

Financial numbers in JPY